True Wealth Design »

Lyell Immunopharma shares owned by True Wealth Design

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by True Wealth Design from 13F filings

Historical chart of True Wealth Design investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by True Wealth Design consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by True Wealth Design

Quarter filed Position value Share count Share price at filing
2024-09-30 $432 313 1.38

More positions owned by True Wealth Design

Ea Series Trust Alpha Arch 1-3 (BOXX)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Emerging Mkts Va (DFEV)
Dimensional Etf Trust Intl High Profit (DIHP)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Val (DFSV)
T Rowe Price Etf Floating Rate (TFLR)
American Centy Etf Tr Us Eqt Etf (AVUS)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)

View all positions for True Wealth Design

Top funds holding Lyell Immunopharma

MWG Management
Orland Properties
BlackRock
BlackRock
Vanguard Group
Foresite Capital Management IV
WuXi AppTec
T. Rowe Price Associates
OrbiMed Advisors
Alphabet
Geode Capital Management
State Street Corporation
Sc China Holding
MIC Capital Management UK
Opaleye Management

View all funds holding Lyell Immunopharma